While most of the big players reported their calendar third-quarter earnings at the end of October, a few other companies reported them in early November. (Also see " Earnings Winners & Losers: BSX, B
In Vitro Diagnostics Acquisitions / In Vitro Diagnostics Becton Dickinson & Co. US Genomics Inc. US Genomics (technologies for diagnostics and biodefense applications) and Becton Dickinson seek t
Measuring the ability of drugs to induce apoptosis (cell death) There aren't many tools which are good at reliably determining the effectiveness of cancer drugs. Immortalized cell lines have long been
Cancer diagnostics has been a tough field for companies. But the need for good tests remains, and with new technologies being discovered, the opportunities still seem worth pursuing. Witness the deals